Impetigo Therapeutics- Pipeline Analysis 2018, Clinical Trials & Results

Impetigo is a common bacterial infection caused by different kinds of bacteria, including streptococcus and staphylococcus. It is a contagious disease and begins with appearance of red sores on any part of the body, which eventually changes to blisters on the body.

Download the sample report @ https://www.pharmaproff.com/request-sample/1064

Impetigo is more common in warm and humid weather, is known to easily transmit in crowded settings like schools and day care. Impetigo can be treated by topical antibiotics, oral antibiotics and some home remedies.

Get the detailed analysis @ https://www.pharmaproff.com/report/impetigo-therapeutics-pipeline-analysis

It is mostly found in children, especially boys, but may also affect adults if they have a weak immune system. Foamix Pharmaceuticals is in the process of developing FMX102 for the treatment of impetigo. Destiny Pharma plc is also involved in the pipeline for impetigo therapeutics.

Make enquiry before purchase @ https://www.pharmaproff.com/enquiry/1064

  • The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials.
  • Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

  About Us:

Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.

Contact:
Pharma Proff
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@pharmaproff.com

Web: https://www.pharmaproff.com

Connect with us on: LinkedIn | Twitter | Facebook

Matched content

Editor’s pick

Express Press Release Distribution